Old Web
English
Sign In
Acemap
>
Paper
>
ATIM-13. PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS TARGETING IL13Rα2 FOR THE TREATMENT OF GLIOBLASTOMA
ATIM-13. PHASE I STUDY OF CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T CELLS TARGETING IL13Rα2 FOR THE TREATMENT OF GLIOBLASTOMA
2016
Christine E. Brown
Darya Alizadeh
Renate Starr
Lihong Weng
Jamie R. Wagner
Araceli Naranjo
Suzette Blanchard
Julie Kilpatrick
Jennifer Simpson
Ressler Ja
Michael C. Jensen
Jana Portnow
Massimo D’Apuzzo
Michael E. Barish
Stephen J. Forman
Behnam Badie
Keywords:
Immunology
Chimeric antigen receptor
Glioblastoma
Cancer research
Medicine
phase i study
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]